Relaxant effects of isoproterenol and selective beta3-adrenoceptor agonists on normal, low compliant and hyperreflexic human bladders.
about
The efficacy and tolerability of mirabegron, a β3 adrenoceptor agonist, in patients with symptoms of overactive bladderThe role of beta(3)-adrenoceptors in mediating relaxation of porcine detrusor muscleBeta3-adrenoceptor agonists: possible role in the treatment of overactive bladderβ-Adrenergic receptor subtype expression in myocyte and non-myocyte cells in human female bladder.Prospective pharmacologic therapies for the overactive bladderFunctional and molecular evidence for Kv7 channel subtypes in human detrusor from patients with and without bladder outflow obstruction.Postmenopausal overactive bladderAlpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate.Potential therapeutic targets for the treatment of detrusor overactivity.Mirabegron relaxes urethral smooth muscle by a dual mechanism involving β3 -adrenoceptor activation and α1 -adrenoceptor blockadeCurrent and emerging investigational medical therapies for the treatment of overactive bladder.Stimulation of beta3-adrenoceptors relaxes rat urinary bladder smooth muscle via activation of the large-conductance Ca2+-activated K+ channels.Urinary incontinence in the young woman: treatment plans and options available.Solabegron: a potential future addition to the β-3 adrenoceptor agonist armamentarium for the management of overactive bladder.Early investigational β3 adreno-receptor agonists for the management of the overactive bladder syndrome.Autonomic Receptor-mediated Regulation of Production and Release of Nitric Oxide in Normal and Malignant Human Urothelial Cells.Current and future pharmacotherapy for treating overactive bladder.Effects of beta(3)-adrenoceptor stimulation on prostaglandin E(2)-induced bladder hyperactivity and on the cardiovascular system in conscious rats.Functional investigation of β-adrenoceptors in human isolated detrusor focusing on the novel selective β3-adrenoceptor agonist KUC-7322.Investigations into the presence of functional Beta1, Beta2 and Beta3-adrenoceptors in urothelium and detrusor of human bladder.Effects of a novel beta(3)-adrenoceptor agonist, AJ-9677, on relaxation of the detrusor muscle: an in vitro study.Relaxant effects of beta-adrenergic agonists on porcine and human detrusor muscle.Modulation of non-voiding activity by the muscarinergic antagonist tolterodine and the β(3)-adrenoceptor agonist mirabegron in conscious rats with partial outflow obstruction.Mucosa of human detrusor impairs contraction and β-adrenoceptor-mediated relaxation.Pathways Involving Beta-3 Adrenergic Receptors Modulate Cold Stress-Induced Detrusor Overactivity in Conscious Rats.Bladder selectivity of the novel β₃-agonist ritobegron (KUC-7483) explored by in vitro and in vivo studies in the rat.
P2860
Q26770419-40C5AD34-CD4D-46D2-9E04-33FF7E4CB850Q28344865-C8B2FD6B-7D30-4059-90EF-84B1986C9D1BQ34468669-67F9FBAE-459C-402D-A0D1-337ED67EFD8EQ35040830-BAF6DB08-EE2B-4943-BC5D-83B766383887Q35076367-2169F77E-DA80-4658-8408-739BB89036E2Q35098568-7DBB5A51-636E-45A9-AE8D-FEB3BBA18A05Q35157329-8EEB8C05-678E-4B30-8C25-33C528958091Q35545711-F2A95661-AE15-4326-8ED5-F1D245743356Q35753357-13DE115F-E16F-4777-B58F-86BE4185DE59Q36506889-1171DEED-78A1-4442-91B3-98ACC3D1AC55Q36568728-0C0892B3-0BDC-463B-9F83-740B9B651851Q36977701-041EA9AE-328C-45EC-90FF-866FCFC435BBQ38193878-16E34430-93FF-4016-99A1-16F5F8D70A04Q38306806-88D58640-41BA-4D93-BD82-2F19CEC6DA66Q38570412-4E622FFA-5966-4EFE-9AC0-A4ED514A0938Q38706325-E3089F75-C143-42E0-818B-98D6B1717525Q38851523-92228527-46CC-417A-B5B9-3C6B8BCE91F8Q44181594-6474E414-E788-4C06-8F3B-FFE889EC5366Q45389301-3A9395D7-D0AA-40B9-A1A6-D5A63557DFC6Q46103322-1EC835AD-904C-4A6C-871B-5BF63207B086Q46176773-F51CBD78-2552-4FB4-BC4A-02851B476F33Q46707423-A186D230-E391-4358-8FF9-9D391450D08CQ47576107-37884DC7-E491-4D0A-ACE8-F9949C850CDCQ47797761-BFC9B6DD-C9CE-40FE-9650-A0967C0B0844Q50951963-9AF11D8A-CE0B-498E-97DD-0F43CF43E96FQ51759362-3814C358-0E17-414B-82D0-09C637742EA3
P2860
Relaxant effects of isoproterenol and selective beta3-adrenoceptor agonists on normal, low compliant and hyperreflexic human bladders.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Relaxant effects of isoprotere ...... hyperreflexic human bladders.
@en
Relaxant effects of isoprotere ...... hyperreflexic human bladders.
@nl
type
label
Relaxant effects of isoprotere ...... hyperreflexic human bladders.
@en
Relaxant effects of isoprotere ...... hyperreflexic human bladders.
@nl
prefLabel
Relaxant effects of isoprotere ...... hyperreflexic human bladders.
@en
Relaxant effects of isoprotere ...... hyperreflexic human bladders.
@nl
P2093
P1476
Relaxant effects of isoprotere ...... hyperreflexic human bladders.
@en
P2093
Andersson KE
Nishizawa O
Yamazaki Y
Yoneyama T
P304
P356
10.1097/00005392-200101000-00071
P407
P577
2001-01-01T00:00:00Z